ZA97614B - Biologically active more particularly peptide molecules having a potentiating effect on the biological activity of growth hormone - Google Patents

Biologically active more particularly peptide molecules having a potentiating effect on the biological activity of growth hormone

Info

Publication number
ZA97614B
ZA97614B ZA97614A ZA97614A ZA97614B ZA 97614 B ZA97614 B ZA 97614B ZA 97614 A ZA97614 A ZA 97614A ZA 97614 A ZA97614 A ZA 97614A ZA 97614 B ZA97614 B ZA 97614B
Authority
ZA
South Africa
Prior art keywords
biological activity
biologically active
growth hormone
peptide molecules
potentiating effect
Prior art date
Application number
ZA97614A
Other languages
English (en)
Inventor
Daniel Portetelle
Rovert Renaville
Original Assignee
Carelli Claude Marcel Henri
Hebert Etienne Francois Marcel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Carelli Claude Marcel Henri, Hebert Etienne Francois Marcel filed Critical Carelli Claude Marcel Henri
Publication of ZA97614B publication Critical patent/ZA97614B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/3955Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/184Hormones
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/168Steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/06Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/61Growth hormone [GH], i.e. somatotropin
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/05Animals comprising random inserted nucleic acids (transgenic)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fodder In General (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ZA97614A 1996-01-26 1997-01-24 Biologically active more particularly peptide molecules having a potentiating effect on the biological activity of growth hormone ZA97614B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9600956A FR2744123B1 (fr) 1996-01-26 1996-01-26 Molecules biologiquement actives plus particulierement peptidiques ayant un effet potentialisateur de l'activite biologique de l'hormone de croissance

Publications (1)

Publication Number Publication Date
ZA97614B true ZA97614B (en) 1997-07-31

Family

ID=9488527

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA97614A ZA97614B (en) 1996-01-26 1997-01-24 Biologically active more particularly peptide molecules having a potentiating effect on the biological activity of growth hormone

Country Status (15)

Country Link
US (1) US6455049B1 (ja)
EP (1) EP0877807B1 (ja)
JP (1) JP2000509964A (ja)
CN (1) CN1130459C (ja)
AR (1) AR005559A1 (ja)
AT (1) ATE243749T1 (ja)
AU (1) AU722064B2 (ja)
BR (1) BR9707067A (ja)
CA (1) CA2243845C (ja)
DE (1) DE69723055T2 (ja)
ES (1) ES2202571T3 (ja)
FR (1) FR2744123B1 (ja)
NZ (1) NZ326401A (ja)
WO (1) WO1997027298A1 (ja)
ZA (1) ZA97614B (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ387599A0 (en) * 1999-11-05 1999-12-02 Metabolic Pharmaceuticals Limited Product and method for control of obesity
FR2833012B1 (fr) * 2001-12-04 2004-01-30 Centre Nat Rech Scient Peptides agonistes de l'hormone de croissance et leurs applications
GB201321242D0 (en) * 2013-12-02 2014-01-15 Immune Targeting Systems Its Ltd Immunogenic compound
US9119832B2 (en) 2014-02-05 2015-09-01 The Regents Of The University Of California Methods of treating mild brain injury
US20170121385A1 (en) 2015-10-28 2017-05-04 Oxeia Biopharmaceuticals, Inc. Methods of treating neurodegenerative conditions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5143726A (en) * 1986-12-09 1992-09-01 The Scripps Research Institute T cell epitopes of the hepatitis B virus nucleocapsid protein
GB8718937D0 (en) * 1987-08-11 1987-09-16 Coopers Animal Health Biologically active molecules
US5843453A (en) * 1992-09-07 1998-12-01 Biotechnology And Biological Sciences Research Council Growth hormone potentiating molecules

Also Published As

Publication number Publication date
CA2243845C (fr) 2012-10-09
AR005559A1 (es) 1999-06-23
AU722064B2 (en) 2000-07-20
ATE243749T1 (de) 2003-07-15
ES2202571T3 (es) 2004-04-01
DE69723055D1 (de) 2003-07-31
CA2243845A1 (fr) 1997-07-31
CN1130459C (zh) 2003-12-10
BR9707067A (pt) 1999-12-28
FR2744123B1 (fr) 1998-04-17
AU1449297A (en) 1997-08-20
WO1997027298A1 (fr) 1997-07-31
CN1209841A (zh) 1999-03-03
NZ326401A (en) 2000-03-27
EP0877807A1 (fr) 1998-11-18
EP0877807B1 (fr) 2003-06-25
FR2744123A1 (fr) 1997-08-01
DE69723055T2 (de) 2004-04-01
US6455049B1 (en) 2002-09-24
JP2000509964A (ja) 2000-08-08

Similar Documents

Publication Publication Date Title
AU7908098A (en) Biologically active 1,3-bis-aromatic-prop-2-en-1-ones, 1,3-bis-aromatic-propan-1-ones, and 1,3-bis-aromatic-prop-2-yn-1-ones
PL339463A1 (en) April - novel protein of growth promoting action
AU8166098A (en) Removal of biologically active agents
AU1082299A (en) Manure treatment system
AU4217197A (en) Biologically active phosphotriester-type compounds
AU5743194A (en) Treatment of dermatological malignancies with biologically active peptides
IL127043A0 (en) Solid-phase activity assay for biologically active substance
ZA97614B (en) Biologically active more particularly peptide molecules having a potentiating effect on the biological activity of growth hormone
ZA9610354B (en) Biologically active benzothiazolone ethanamines
ZA968230B (en) Administration of biologically active material
PL338856A1 (en) Dried biologically or therapeutically active preparations
AU7609298A (en) Treatment of heart failure with growth hormone
AU1720097A (en) Biologically active ureido derivatives useful in the treatment of multiple sclerosis
AU2766597A (en) Biologically active protein (collagen fragment hf-coll-18/514cf) for inhibiting the growth of tumours and capillary profilerations
AU6867998A (en) Human growth and differentiation protein
AU6582694A (en) Biologically active peptides
GB9402189D0 (en) Biologically active formulations
AU5378396A (en) Peptide growth factor having epidermal inducing activity
AU3109895A (en) Spherical microparticles comprising a nucleation promoter and biologically active compounds
GB9310608D0 (en) Biologically active dermatological treatment
GB9218772D0 (en) Biologically active dermatological treatment
PL104421U1 (en) Biologically active re-radiator
GB9711697D0 (en) Biologically and therapeutically active agents
GB9616822D0 (en) Biologically and therapeutically active agents
GB9615504D0 (en) Biologically and therapeutically active agents